Tezepelumab did not significantly decrease moderate or severe COPD exacerbations compared with placebo, the COURSE trial found.

Elevated CAR has been associated with adverse outcomes in many conditions, including cancer, sepsis, COVID-19, and cardiovascular diseases. A higher C-reactive protein to albumin ratio (CAR) is ...

This achievement has been recognised by the Asia Book of Records for engaging the largest number of doctors in a COPD ...

Chronic pain is a common complaint among those with COPD. Columnist Caroline Gainer shares the pain relief strategies that ...

A recent trial showed that nicotinamide riboside supplementation might reduce airway inflammation in patients with COPD who ...

In today’s fast-paced world, respiratory issues have become increasingly common, affecting individuals of all ages. Whether it’s due to environmental pollutants, allergens, or chronic conditions like ...

We've all felt winded when taking the stairs or dealt with a cough from time to time. But if these issues linger, they could ...

As contemporary surgical practice continues to evolve, patients who undergo surgical lung volume reduction (LVRS) for ...

Chronic obstructive pulmonary disease (COPD) and other lower respiratory diseases are among leading causes of U.S. deaths per ...

Explore strategies for controlling COPD and improving health, with a focus on management and lifestyle changes.

Researchers have identified new lung function and blood test cutoffs to improve timely chronic hypercapnia management in ...